Elucid
Healthcare & Life Sciences
Recent Finacing
Series C
Recent Raise
$80M
Elucid is a Boston-based medical technology company that has developed AI-powered non-invasive diagnostic tools for cardiovascular risk evaluation, including the FDA-cleared PlaqueIQ software for characterizing arterial plaque and non-invasive measurement of fractional flow reserve.
Focus Areas
Medical technology
AI-powered diagnostic tools
Cardiovascular risk evaluation
Imaging analysis software
Non-invasive arterial plaque characterization
Fractional flow reserve measurement
Investors
